FRA:5UM (China)
Â
Shs Unitary 144A/Reg S
€
0.48
-0.0020 (-0.41%)
Aug 20
Business Description
Genertec Universal Medical Group Co Ltd
ISIN : HK0000255361
Share Class Description:
FRA:5UM: Shs Unitary 144A/Reg STotal Employee Number:
23,791Compare
Compare
Traded in other countries / regions
02666.Hong Kong5UM.Germany IPO Date
2015-07-10Description
Genertec Universal Medical Group Co Ltd is principally engaged in providing financing to its customers under finance lease arrangements, the provision of advisory services, the sale of medical equipment as well as leases under operating lease arrangements, and the provision of other services. The group has two business segments namely The finance business comprises direct finance leasing, sale-and-leaseback, factoring, operating leases, and advisory services; and Healthcare business comprises includes hospital group business, healthcare technology business and specialty business. Geographically, it derives a majority of its revenue from Mainland China.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 2.52 | |||||
Debt-to-EBITDA | 13.68 | |||||
Interest Coverage | 47 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 0.71 | |||||
Beneish M-Score | -2.6 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.1 | |||||
3-Year EBITDA Growth Rate | 7.6 | |||||
3-Year EPS without NRI Growth Rate | 5.8 | |||||
3-Year FCF Growth Rate | 51.2 | |||||
3-Year Book Growth Rate | 7.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 3.25 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | -10 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.98 | |||||
9-Day RSI | 37.65 | |||||
14-Day RSI | 39.84 | |||||
3-1 Month Momentum % | -11.21 | |||||
6-1 Month Momentum % | -20.16 | |||||
12-1 Month Momentum % | -18.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.37 | |||||
Quick Ratio | 1.33 | |||||
Cash Ratio | 0.08 | |||||
Days Inventory | 23.62 | |||||
Days Sales Outstanding | 748.21 | |||||
Days Payable | 98.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 8.33 | |||||
Dividend Payout Ratio | 0.27 | |||||
3-Year Dividend Growth Rate | 1 | |||||
Forward Dividend Yield % | 8.33 | |||||
5-Year Yield-on-Cost % | 9.42 | |||||
3-Year Average Share Buyback Ratio | -2.1 | |||||
Shareholder Yield % | 5.23 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 33.67 | |||||
Operating Margin % | 21.83 | |||||
Net Margin % | 14.78 | |||||
EBITDA Margin % | 25.94 | |||||
FCF Margin % | 32.05 | |||||
OCF Margin % | 38.68 | |||||
ROE % | 11.41 | |||||
ROA % | 2.61 | |||||
ROIC % | 3.25 | |||||
3-Year ROIIC % | -1.68 | |||||
ROC (Joel Greenblatt) % | 9.09 | |||||
ROCE % | 5.41 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 3.85 | |||||
Forward PE Ratio | 3.57 | |||||
PE Ratio without NRI | 3.5 | |||||
Shiller PE Ratio | 4.52 | |||||
Price-to-Owner-Earnings | 2.56 | |||||
PEG Ratio | 2.06 | |||||
PS Ratio | 0.57 | |||||
PB Ratio | 0.4 | |||||
Price-to-Tangible-Book | 0.41 | |||||
Price-to-Free-Cash-Flow | 1.75 | |||||
Price-to-Operating-Cash-Flow | 1.45 | |||||
EV-to-EBIT | 21.25 | |||||
EV-to-Forward-EBIT | 0.02 | |||||
EV-to-EBITDA | 16.93 | |||||
EV-to-Forward-EBITDA | 0.02 | |||||
EV-to-Revenue | 4.39 | |||||
EV-to-FCF | 13.82 | |||||
Price-to-GF-Value | 1 | |||||
Price-to-Projected-FCF | 0.34 | |||||
Price-to-DCF (Earnings Based) | 0.24 | |||||
Price-to-DCF (FCF Based) | 0.05 | |||||
Price-to-Median-PS-Value | 0.51 | |||||
Price-to-Graham-Number | 0.25 | |||||
Earnings Yield (Greenblatt) % | 4.7 | |||||
FCF Yield % | 56.95 | |||||
Forward Rate of Return (Yacktman) % | 13.79 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genertec Universal Medical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,807.603 | ||
| EPS (TTM) (€) | 0.131 | ||
| Beta | 0.1369 | ||
| 3-Year Sharpe Ratio | 0.09 | ||
| 3-Year Sortino Ratio | 0.13 | ||
| Volatility % | 16.04 | ||
| 14-Day RSI | 39.84 | ||
| 14-Day ATR (€) | 0.009869 | ||
| 20-Day SMA (€) | 0.4947 | ||
| 12-1 Month Momentum % | -18.25 | ||
| 52-Week Range (€) | 0.47 - 0.725 | ||
| Shares Outstanding (Mil) | 2,014.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genertec Universal Medical Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genertec Universal Medical Group Co Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| HKD 0.360000 Cash Dividend | 2026-06-26 | 0.54 (+4.90%) | ||
| HKD 0.350000 Cash Dividend | 2025-06-12 | 0.59 (+0.00%) |
Show
Entries
Genertec Universal Medical Group Co Ltd Frequently Asked Questions
What is Genertec Universal Medical Group Co Ltd(FRA:5UM)'s stock price today?
The current price of FRA:5UM is €0.48. The 52 week high of FRA:5UM is €0.73 and 52 week low is €0.47.
When is next earnings date of Genertec Universal Medical Group Co Ltd(FRA:5UM)?
The next earnings date of Genertec Universal Medical Group Co Ltd(FRA:5UM) is .
Does Genertec Universal Medical Group Co Ltd(FRA:5UM) pay dividends? If so, how much?
The Dividend Yield %  of Genertec Universal Medical Group Co Ltd(FRA:5UM) is 8.33% (As of Today), Highest Dividend Payout Ratio of Genertec Universal Medical Group Co Ltd(FRA:5UM) was 0.33. The lowest was 0.21. And the median was 0.25. The  Forward Dividend Yield % of Genertec Universal Medical Group Co Ltd(FRA:5UM) is 8.33%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Genertec Universal Medical Group Co Ltd
No articles.